Dublin, Feb. 01, 2017 -- Research and Markets has announced the addition of the "Global Orthopedic Biomaterials Market - By Type, By Sub-Type, By Application: Analysis By Region, By Country (2011-2021)" report to their offering.
Global Orthopaedic Biomaterial Market is forecasted to grow at a CAGR of 13.19% during 2016-2021.
Due to growing problem of osteoarthritis, bone preservation, less healing time and technological advancement like minimally invasive surgeries has led to an increase in the orthopaedic biomaterial market.
Growing demand for biodegradable and biocompatible product is increasing surging prevalence of Arthritis, Bone degeneration, Obesity and Diabetes among geriatric population. Also, the inclination of young population towards adapting such products has been driving the market.
Global Orthopaedic Biomaterial Market is forecasted to grow at a CAGR of 13.19 % during 2016-2021F, driven by rising clinical education among the patients, increasing medical applications of biomaterial by orthopaedicians, rising demand from the aged population, and technological innovation has further led to growing focus towards healthcare, hence, building the need for joint replacement surgeries using orthopaedic biomaterial, specifically among the adult population.
While the market has witnessed strong foothold in the regions of North America and Europe, however rapid growth is expected to be driven by the emerging nations in Asia Pacific and ROW.
The report provides coverage by Material Type, Metal Sub Type, Non-Metal Sub Type and By Application:
By Material Type
- Metal Orthopaedic Biomaterial
- Non-Metal Orthopaedic Biomaterial
By Metal Type
- Stainless Steel
- Titanium Alloys
- Cobalt-Chromium Alloys
- Others
By Non-Metal Type
- Polymer
- Ceramic
- Composite
By Polymer Type
- UHMWPE
- PEEK
- Fiber Reinforced Polymers
- Others
By Ceramic Type
- Bioinert Ceramic
- Bioactive Ceramics
By Composite Type
- PMMA
- Others
By Application
- Joint Replacement
- Spine Implant
- Oestosynthesis
- Orthobilogics
Key Topics Covered:
1. Research Methodology
2. Executive Summary
3. Strategic Recommendation
4. Global Orthopaedic Biomaterials Market
5. Global Orthopaedic Biomaterials Market: By Material Type (Metals and Non Metals)
6. Global Metal Orthopaedic Biomaterials Market: By Sub Type (Stainless Steel, Titanium Alloys, Cobalt-Chromium Alloys, Others)
7. Global Non-Metal Orthopaedic Biomaterials Market: By Sub Type (Polymer, Ceramic and Composites)
8. Global Polymer Orthopaedic Biomaterials Market
9. Global Ceramics Orthopaedic Biomaterial Market
10. Global Composite Orthopaedic Biomaterial Market
11. Global Orthopaedic Biomaterial Market: By Application (Joint Replacement, Spine Implant, Osteosynthesis, Orthobiologics)
12. Global Orthopaedic Biomaterial Market: By Regional Breakdown
13. North America Orthopaedic Biomaterial Market: Growth and Forecast
14. North America Orthopaedic Biomaterials Market: Country Analysis
15. Europe Orthopaedic Biomaterial Market: Growth and Forecast
16. Europe Orthopaedic Biomaterials Market: Country Analysis
17. APAC Orthopaedic Biomaterial Market: Growth and Forecast
18. APAC Orthopaedic Biomaterials Market: Country Analysis
19. ROW Orthopaedic Biomaterial Market: Growth and Forecast
20. ROW Orthopaedic Biomaterials Market: Country Analysis
21. Market Dynamics
22. Market Trends
23. SWOT Analysis - Orthopaedic Biomaterial Market
24. Porter's Five Forces Analysis - Orthopaedic Biomaterial Market
25. Policy and Regulatory Landscape
Company Profiling
- Acumed
- Amedica Corporation
- Exactech Inc.
- Globus Medical
- Johnson & Johnson
- Koninklijke DSM N.V.
- Medtronic PLC
- Stryker Corporation
- Wright Medical Group
- Zimmer Biomet Holdings Inc.
For more information about this report visit http://www.researchandmarkets.com/research/8qj47j/global_orthopedic
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Biomaterials


Microsoft Eyes $7B Texas Energy Deal to Power AI Data Centers
Ford Issues Major Recall on Over 422,000 Vehicles Due to Windshield Wiper Defect
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports
OpenAI Executive Shake-Up Ahead of Anticipated 2026 IPO
LG Electronics Posts Record Q1 Revenue Amid Strong Demand and Cost Improvements
Samsung Electronics Posts Eightfold Profit Surge Driven by AI Chip Demand
Apple Turns 50: From Garage Startup to AI Crossroads
Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook
TSMC Japan's Second Fab to Produce 3nm Chips by 2028
Microsoft's $10 Billion Japan Investment: AI Infrastructure and Data Sovereignty Push
Deere & Company Agrees to $99 Million Settlement Over Right-to-Repair Dispute
MATCH Act Targets ASML and Chinese Chipmakers in New U.S. Export Crackdown
Fonterra Admits Anchor Butter "Grass-Fed" Label Misled Consumers After Greenpeace Lawsuit
SpaceX IPO: Retail Investors to Play Historic Role in Record-Breaking Public Offering
Paramount Skydance Secures $24B from Gulf Sovereign Wealth Funds for Warner Bros. Discovery Takeover
Private Credit Under Pressure: Is a Slow-Motion Crisis Unfolding? 



